Respiratory syncytial virus (RSV) gets noses running, but in the last few days it’s also got tongues wagging — ever since it was revealed a new...
CNN — After 60 years of scientific research, the world has the first vaccine to protect against respiratory syncytial virus (RSV). on Wednesday, U.S. Food and...
“Early studies have shown that these treatment options may reduce the serious consequences of COVID-19, such as hospitalization and death,” according to a statement from the...
Newly infected COVID-19 patients have two new treatment options that can be taken at home Along Tom Murphy AP Health Writer December 26, 2021 14:59 ••...
With GlaxoSmithKline, Pfizer and more in operation, Johnson & Johnson may need good data to win the RSV vaccine market.Big Pharma further demonstrated its qualifications on...
Sotrovimab (GlaxoSmithKline), a monoclonal antibody, appears to reduce the risk of progression in mild to moderate cases of COVID-19 in patients at high risk of progression,...
Recent Comments